Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Aug 15, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a special prevention program designed to help reduce the risk of latent rheumatic heart disease in schoolchildren in Nepal. Rheumatic heart disease can occur after untreated strep throat and can lead to serious heart problems. The goal of the trial is to see if this school-centered program can effectively lower the number of children affected by this condition and to understand how factors like family income and living conditions might influence the development of the disease.

To participate in the trial, children must be between 5 and 16 years old and currently attending Tulsi Secondary Boarding School in Tulsipur, Nepal. If a child or their parent agrees to take part, they will be involved in activities and screenings related to the prevention program. It’s important to note that children whose parents do not provide consent or who do not attend the school cannot join the study. This trial aims to provide valuable insights that could help improve children's heart health in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 5-16 years
• • Attending Tulsi Secondary Boarding School in Tulsipur, Nepal.
• Exclusion Criteria:
• • Children / primary caregivers not providing informed consent to participate
• • Children not attending Tulsi Secondary Boarding School in Tulsipur.